Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


J. Nutr. (June 3, 2009). doi:10.3945/jn.109.104471
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
139/7/1347    most recent
jn.109.104471v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Raff, M.
Right arrow Articles by Mandrup, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raff, M.
Right arrow Articles by Mandrup, S.
© 2009 American Society for Nutrition


Nutrition and Disease

Conjugated Linoleic Acids Reduce Body Fat in Healthy Postmenopausal Women1,2,3

Marianne Raff4,*, Tine Tholstrup4, Søren Toubro4, Jens M. Bruun5, Pia Lund6, Ellen M. Straarup6, Robin Christensen7, Maria B. Sandberg8 and Susanne Mandrup8

4 Department of Human Nutrition, Faculty of Life, University of Copenhagen, Frederiksberg 1958, Denmark 5 Department of Endocrinology and Metabolism C, Aarhus University Hospital, DK-8000 Aarhus C, Denmark 6 Biochemistry and Nutrition Group, BioCentrum-DTU, Technical University of Denmark, Lyngby 2800, Denmark 7 Parker Institute, Musculoskeletal Statistics Unit, Frederiksberg Hospital, Frederiksberg C 2000, Denmark 8 Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense 5000, Denmark

Isomers of conjugated linoleic acids (CLA) reduce fat mass (FM) and increase insulin sensitivity in some, but not all, murine studies. In humans, this effect is still debatable. In this study, we compared the effect of 2 CLA supplements on total and regional FM assessed by dual energy X-ray absorptiometry, changes in serum insulin and glucose concentrations, and adipose tissue (AT) gene expression in humans. In a double-blind, parallel, 16-wk intervention, we randomized 81 healthy postmenopausal women to 1) 5.5 g/d of 40/40% of cis9,trans11-CLA (c9,t11-CLA) and trans10,cis12-CLA (t10,c12-CLA) (CLA-mix); 2) cis9, trans11-CLA (c9,t11-CLA); or 3) control (olive oil). We assessed all variables before and after the intervention. The CLA-mix group had less total FM (4%) and lower-body FM (7%) than the control (P = 0.02 and < 0.001, respectively). Post hoc analyses showed that serum insulin concentrations were greater in the CLA-mix group (34%) than the control group (P = 0.02) in the highest waist circumference tertile only. AT mRNA expression of glucose transporter 4, leptin, and lipoprotein lipase was lower, whereas expression of tumor necrosis factor-{alpha} was higher in the CLA-mix group than in the control group (P < 0.04). In conclusion, a 50:50 mixture of c9,t11- and t10,c12-CLA isomers resulted in less total and lower-body FM in postmenopausal women and greater serum insulin concentrations in the highest waist circumference tertile. Future research is needed to confirm the insulin desensitizing effect of the CLA mixture and the effect on the mRNA expression of adipocyte-specific genes in humans.


* To whom correspondence should be addressed. E-mail: mrf{at}life.ku.dk.

Manuscript received 27 January 2009. Initial review completed 13 March 2009. Revision accepted 14 May 2009.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2009 by American Society for Nutrition